头孢喹诺对鸡大肠杆菌病的疗效

Efficacy of Cefquinome in the Treatment of Avian Colibacillosis

市场上对于鸡蛋及鸡肉产品的需求量不断提升,我国鸡养殖规模正处于不断扩大阶段,然而在一定程度上也增加了鸡出现疫病的概率。鸡大肠杆菌病是由于致病性大肠埃希氏杆菌导致的传染性疾病,会使鸡出现炎症反应,如果没有及时干预会使鸡群内部出现疾病扩散的现象,给养殖农户带来严重的经济损失。头孢喹诺是专门治疗动物疾病的第4代头孢菌素药物,属于抗生素药物之一,杀菌作用和抗菌作用较好,在鸡大肠杆菌病的治疗过程中能取得较好的治疗效果。为了明确头孢喹诺在鸡大肠杆菌疾病中的治疗效果,该文选择共120只鸡作为研究对象,分成6组进行对照试验。

With the increasing demand for eggs and chicken products in the market,the scale of chicken breeding in China is expanding,but to a certain extent,it also increases the probability of epidemic disease.Avian colibacillosis is an inflammatory reaction in chickens caused by pathogenic escherichia coli infectious disease that can spread the disease within the flock if left untreated,it brings serious economic losses to the breeding farmers.Cefquinome is the 4th generation cephalosporin which is used to treat animal diseases.It is one of the antibiotics.It has good bactericidal and antibacterial effect and can get good therapeutic effect in the treatment of chicken colibacillosis.In order to evaluate the efficacy of cefquinome in the treatment of colibacillosis in chickens,120 chickens were selected and divided into 6 groups.